Formic Ventures is a venture capital firm specializing in seed investments for biotechnology startups focused on human longevity and impactful innovations. The firm's investment strategy targets companies that aim to enhance human lives and put individuals in control of their destiny, with a particular emphasis on fighting entropy.
Notable portfolio companies include Insilico Medicine, Iron Ox, and Framework. Formic Ventures has invested across various stages, from pre-seed to Series C, with a strong focus on seed and Series A rounds. The firm's diverse portfolio spans biotech, pharmaceuticals, and innovative technologies, reflecting its commitment to advancing human potential and meaningful progress.
Formic Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies22
Follow-on Investments3
Current Portfolio Count20
Top Investment Stages
Seed13 (56.5%)
Series A5 (21.7%)
Series B3 (13.0%)
Pre-Seed1 (4.3%)
Series C1 (4.3%)
Stage Mix
Seed 57%Series A 22%Series B 13%Pre-Seed 4%Series C 4%
Concentration shown as share of disclosed investments by stage.
Formic Ventures - Classification
- Also Known As
- Formic Ventures LLC
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 9 more industry codes
- NAICS
- 540000Professional, Scientific, and Technical Services
- 525000Funds, Trusts, and Other Financial Vehicles
- 541000Professional, Scientific, and Technical Services
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 7300Business Services
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
